- Home
- NSPR vs CPHC Comparison
NSPR vs CPHC Comparison
Compare NSPR & CPHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSPR
- CPHC
- Stock Information
- Founded
- NSPR 2005
- CPHC 1994
- Country
- NSPR United States
- CPHC United States
- Employees
- NSPR N/A
- CPHC N/A
- Industry
- NSPR Medical/Dental Instruments
- CPHC Services-Misc. Amusement & Recreation
- Sector
- NSPR Health Care
- CPHC Consumer Discretionary
- Exchange
- NSPR Nasdaq
- CPHC Nasdaq
- Market Cap
- NSPR 75.1M
- CPHC 89.8M
- IPO Year
- NSPR N/A
- CPHC 1994
- Fundamental
- Price
- NSPR $2.44
- CPHC $18.50
- Analyst Decision
- NSPR Strong Buy
- CPHC
- Analyst Count
- NSPR 2
- CPHC 0
- Target Price
- NSPR $4.50
- CPHC N/A
- AVG Volume (30 Days)
- NSPR 386.2K
- CPHC 11.5K
- Earning Date
- NSPR 08-05-2025
- CPHC 08-07-2025
- Dividend Yield
- NSPR N/A
- CPHC 1.51%
- EPS Growth
- NSPR N/A
- CPHC N/A
- EPS
- NSPR N/A
- CPHC 0.16
- Revenue
- NSPR $7,027,000.00
- CPHC $60,605,931.00
- Revenue This Year
- NSPR $4.85
- CPHC N/A
- Revenue Next Year
- NSPR $113.47
- CPHC N/A
- P/E Ratio
- NSPR N/A
- CPHC $114.81
- Revenue Growth
- NSPR 8.49
- CPHC N/A
- 52 Week Low
- NSPR $1.99
- CPHC $16.75
- 52 Week High
- NSPR $3.80
- CPHC $22.93
- Technical
- Relative Strength Index (RSI)
- NSPR 54.16
- CPHC 50.86
- Support Level
- NSPR $2.12
- CPHC $18.35
- Resistance Level
- NSPR $2.46
- CPHC $19.04
- Average True Range (ATR)
- NSPR 0.16
- CPHC 0.66
- MACD
- NSPR 0.01
- CPHC -0.08
- Stochastic Oscillator
- NSPR 73.33
- CPHC 4.60
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
About CPHC Canterbury Park Holding Corporation 'New'
Canterbury Park Holding Corp is in the business of pari-mutuel wagering on horse races and unbanked card games at its canterbury park racetrack and card casino facility in Minnesota. The company has four operating segments. The horse racing segment represents pari-mutuel wagering operations on simulcast and lives horse races; the Casino segment represents unbanked card operations; the food and beverage segment includes concessions, catering, and events services provided at the Racetrack; and the development segment represents its real estate development operations. The firm generates a majority of its revenue from the Casino segment.